Drug intelligence / Profile preview

SophorOx

Development stage
Unknown
Lead developer
Layn Natural Ingredients
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

SophorOx is a proprietary polyphenol-rich antioxidant blend derived from the buds of *Sophora japonica* L (also known as *Styphnolobium japonicum*), standardized to contain at least 90% flavonoids. Its primary active components are quercetin and rutin. Developed as a natural supplement, it is designed to reduce oxidative stress and inflammation in overweight or obese individuals. Mechanistically, it acts by inhibiting pro-inflammatory cytokines such as TNF-α and IL-6 and reducing markers of oxidative stress including malondialdehyde (MDA), 8-isoprostane (8-iso-PGF2α), and 8-hydroxydeoxyguanosine (8-OHdG). Human clinical studies have shown that supplementation with SophorOx leads to significant reductions in oxidative stress biomarkers, improvements in body composition metrics such as weight and waist circumference, and enhanced quality of life measures. Preclinical studies further support its anti-inflammatory effects without notable adverse events[1][2][5][7].

Brand names
SophorOxSophorOx™SophorOx®
Other names
quercetin–rutin blendstandardized sophora japonica extract
02

Targets

TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on SophorOx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SophorOx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call